Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Microbiology (3)
- Medical Specialties (3)
- Oncology (2)
- Behavior and Behavior Mechanisms (1)
- Diseases (1)
-
- Endocrinology, Diabetes, and Metabolism (1)
- Immune System Diseases (1)
- Internal Medicine (1)
- Medical Anatomy (1)
- Medical Biochemistry (1)
- Medical Cell Biology (1)
- Medical Molecular Biology (1)
- Medical Pathology (1)
- Medical Pharmacology (1)
- Nervous System Diseases (1)
- Neurology (1)
- Neurosciences (1)
- Pathological Conditions, Signs and Symptoms (1)
- Psychiatry and Psychology (1)
- Virus Diseases (1)
- Keyword
-
- Adrenal Insufficiency (1)
- Aging (1)
- Apoptosis (1)
- Cancer (1)
- Cognitive decline (1)
-
- Colorectal Carcinoma (1)
- Demyelinating Diseases (1)
- Drug Resistance (1)
- Drug resistance (1)
- Flowcytometry (1)
- Galectin-1 (1)
- Hepatocellular carcinoma (1)
- Herpes zoster (1)
- Hypothyroidism (1)
- Immunosuppressed treatment (1)
- Immunosuppression (1)
- Immunosurveillance (1)
- JC Virus (1)
- LncRNA UCA1 (1)
- Microglia (1)
- Neuroinflammation (1)
- Non-enhancing brain lesions (1)
- Oncogenesis (1)
- Oral Cancer (1)
- Pembrolizumab (1)
- Progressive Multifocal Leukoencephalopathy (1)
- Reactivation (1)
- Regorafenib (1)
- TDG (1)
- Tregs (1)
Articles 1 - 8 of 8
Full-Text Articles in Medical Immunology
An Endocrine Enigma: The Implications Of Pembrolizumab Therapy, Miguel A. Lopez, Mario Trujillo Acosta, Jose Romero Villarreal Calderon, Laura Garcia
An Endocrine Enigma: The Implications Of Pembrolizumab Therapy, Miguel A. Lopez, Mario Trujillo Acosta, Jose Romero Villarreal Calderon, Laura Garcia
Research Symposium
Disorders of the endocrine system are a potential complication of cancer treatment despite newer immunotherapy agents holding promise to improve patient outcomes. Breast cancer in particular requires pharmacologic intervention based on the receptor positivity. For example, a triple negative workup often requires neoadjuvant therapy with the newer immunotherapy agent pembrolizumab. Clinicians should be aware of the potential adverse effects of this drug, most notably adrenal insufficiency. This case follows a 52 year old hispanic female patient with a history of triple negative left sided breast cancer on immunotherapy with pembrolizumab, who presented to the emergency department after a syncopal episode …
Progressive Multifocal Leukoencephalopathy (Pml) Induced By Jc Virus: A Case Report And Review Of Clinical Implications, Hugo Zamarron, Roberto Cruz
Progressive Multifocal Leukoencephalopathy (Pml) Induced By Jc Virus: A Case Report And Review Of Clinical Implications, Hugo Zamarron, Roberto Cruz
Research Symposium
Background: Progressive multifocal leukoencephalopathy (PML) is a rare but serious demyelinating disease of the central nervous system, caused by the John Cunningham (JC) virus. While the JC virus is common in the general population, it remains dormant in healthy individuals but can reactivate in immunocompromised patients, particularly those with HIV/AIDS or undergoing immunosuppressive treatments for organ transplants or autoimmune conditions. The virus attacks oligodendrocytes, leading to demyelination and significant neurological deficits. Immunosuppressive therapies such as natalizumab, rituximab, and mycophenolate increase the risk of PML. Diagnosing PML is challenging as its symptoms—focal neurological deficits, sensory-motor issues, and visual disturbances—overlap with conditions …
Exploring The Mechanisms Of Varicella-Zoster Virus Pathogenesis And Its Potential Role In Oncogenesis, Fernando Cisneros, Blake Martin
Exploring The Mechanisms Of Varicella-Zoster Virus Pathogenesis And Its Potential Role In Oncogenesis, Fernando Cisneros, Blake Martin
Research Symposium
Background: Varicella-zoster virus (VZV) is a highly prevalent pathogen primarily recognized for causing chickenpox during primary infection and herpes zoster (HZ), also known as shingles, upon reactivation. While post-infectious complications of VZV, such as encephalitis, pneumonia, and post-herpetic neuralgia, are well-established, recent large population-based studies suggest that HZ may increase the risk of occult cancers. Emerging evidence suggests that VZV may modulate key oncogenic pathways, such as the inhibition of apoptosis, alteration of cell cycle regulatory enzymes, and interference with immunosurveillance, which could potentially promote cancer development. These findings indicate that VZV’s role in cancer biology may involve direct cellular …
Lncrna Impact On Regorafenib Resistance In Colorectal Cancer, Ricardo Pequeno Bracho, Kyle Doxtater, Dennis Kwabiah, Yamile Abuchard Anaya, Sophia Leslie, Mohammad Shabir Hussain, Manish Tripathi
Lncrna Impact On Regorafenib Resistance In Colorectal Cancer, Ricardo Pequeno Bracho, Kyle Doxtater, Dennis Kwabiah, Yamile Abuchard Anaya, Sophia Leslie, Mohammad Shabir Hussain, Manish Tripathi
Research Symposium
Cancer metastasis is one of the deadliest aspects of the disease, with about 90% of all cancer-related deaths due to its development at different sites within the body. Colorectal cancer (CRC) is the second leading cause of cancer mortality in the United States, with 40-50% of all patients developing metastasis at some point during their fight with the disease. With the approval of Regorafenib for treating metastatic colorectal cancer, steps have been taken to combat metastasis in colorectal cancer. A vital aspect of the development of metastasis is the development of resistance to first-line chemotherapy. Regorafenib is an oral small-molecule …
Studying The Molecular Mechanism Of Hepatocellular Carcinoma, Shabnam Malik, Mohammed Sikander, S. Mishra, Daniel Zubieta, S. K. Jain, Deepshikha Pande Katare, Meena Jaggi, Subhash Chauhan
Studying The Molecular Mechanism Of Hepatocellular Carcinoma, Shabnam Malik, Mohammed Sikander, S. Mishra, Daniel Zubieta, S. K. Jain, Deepshikha Pande Katare, Meena Jaggi, Subhash Chauhan
Research Symposium
Background: Hepatocellular carcinoma (HCC) has a poor prognosis due to ineffective therapeutic modality and lack of early diagnostic marker. Accumulating studies have shown that elevated expression of mucin 13 as potential oncogene and predictive biomarker for various cancer. However, very little is known about its expression and function for development and progression of HCC.
Objective: To investigate mucin 13 expression in chemically induced hepatocellular carcinoma model.
Methodology: Diethyl nitrosamine (DEN) and 2-Acetylaminofluorene (2-AAF) induced method was employed for the development of hepatocellular carcinoma in Male Wistar rats. Serum and tissues were collected at regular intervals of time and routinely validated …
Fornix Volumetric Increase During Aging Associates To Microglia Activation Leading To Defective Cognitive Performance, Marcela Cárdenas Tueme, Luis Ángel Trujillo-Villarreal, Victor Ramírez-Amaya, Eduardo Garza-Villarreal, Alberto Camacho-Morales, Diana Reséndez-Pérez
Fornix Volumetric Increase During Aging Associates To Microglia Activation Leading To Defective Cognitive Performance, Marcela Cárdenas Tueme, Luis Ángel Trujillo-Villarreal, Victor Ramírez-Amaya, Eduardo Garza-Villarreal, Alberto Camacho-Morales, Diana Reséndez-Pérez
Research Symposium
Background: Ageing displays a low-grade pro-inflammatory profile in blood and brain. It has been documented proinflammatory cytokines accumulation leading to neuroinflammation during aging. Aged brains integrate pro inflammatory cytokines accumulation, active microglia and volumetric changes which correlates with defective cognitive performance and neurodegeneration.
Methods: Mice from 2-,12- and 20-months-old of age were submitted to different memory tests: Y-maze, Barnes maze, object location test and object location test. Afterwards, we performed structural MRI to evaluate macrostructural changes related to memory and learning regions. Following this, we also evaluated in peripheral blood and in brain tissue the presence of pro-inflammatory cytokines …
Diverse Tregs Population And Effects Of Their Inhibition On Growth Of Oral Cancer Cells, Sadhna Aggarwal, Satya N. Das, Suresh C. Sharma
Diverse Tregs Population And Effects Of Their Inhibition On Growth Of Oral Cancer Cells, Sadhna Aggarwal, Satya N. Das, Suresh C. Sharma
Research Symposium
Oral squamous cell carcinoma (OSCC) is one of the major cancers affecting in Asian countries. The main causative factor has been tobacco habit. It has been reported that immune dysfunction in these patients is one of the major factors for tumor growth and dissemination that affects disease free survival of the patients.
We assessed the phenotypic and functional characteristics of Regulatory T (Treg) CD4+CD25+FoxP3+subsets in patients with OSCC by multicoloured flow cytometry. Subsequently we investigated the effects their inhibition via TDG on growth of OSCC cell lines in vitro.
An increased (p
Hence, it seems reasonable to assume that modulation …
Ybx1 Modulates Drug Resistance In Liver Cancer, Ana G. Ayala Pazzi
Ybx1 Modulates Drug Resistance In Liver Cancer, Ana G. Ayala Pazzi
Research Symposium
According to the Texas Cancer Registry, hepatocellular carcinoma (HCC) is the sixth most common cause of cancer death. In 2015, Texas had the country's highest incidence rate and the fourth highest mortality rate. Texas Hispanics (87% of Mexican origin) showed the highest incidence and mortality rates compared to the overall US Hispanic population, with individuals of Mexican origin having the highest rates. The Rio Grande Valley, which is predominantly Mexican, is extremely affected by this fact, which exacerbates the need to address this issue within our community.
A major challenge in improving patient therapy in liver cancer is Sorafenib resistance. …